Target intelligence / Profile preview

Human mitochondrial 12S ribosomal RNA (MT-RNR1) (MT-RNR1)

Target
MT-RNR1
Molecular classification
Ribosomal RNA, Non-coding RNA, Mitochondrial RNA
01

Overview

Human mitochondrial 12S ribosomal RNA (MT-RNR1) is a structural and functional component of the small (28S) subunit of the mitochondrial ribosome, essential for the translation of the 13 proteins encoded by the mitochondrial genome (NCBI Gene: 4549). These proteins are critical components of the oxidative phosphorylation complexes required for ATP production. MT-RNR1 is a significant pharmacological target, particularly as an off-target for aminoglycoside antibiotics like gentamicin and streptomycin. Aminoglycosides bind to the decoding A-site of the 12S rRNA, a site that is evolutionarily conserved from bacteria. In individuals with specific mitochondrial DNA mutations, such as m.1555A>G, the human mitochondrial rRNA becomes more similar to bacterial 16S rRNA, increasing the binding affinity of these drugs (PMID: 8464480). This interaction leads to the inhibition of mitochondrial protein synthesis, resulting in the death of hair cells in the inner ear and subsequent permanent hearing loss (OMIM: 561000). Consequently, MT-RNR1 is a key focus in pharmacogenetics and the prevention of drug-induced ototoxicity.

Other names
12S rRNAMTRNR1Mitochondrially encoded 12S RNASmall subunit ribosomal RNA12S ribosomal RNA
02

Mechanism of action

Aminoglycosides bind to the decoding A-site of the 12S rRNA, causing mistranslation or inhibition of mitochondrial protein synthesis, which leads to cellular toxicity in the inner ear (PMID: 10746561).

03

Biological functions

Mitochondrial translationRibosome assemblyOxidative phosphorylation
04

Disease associations

Aminoglycoside-induced deafnessNonsyndromic hearing lossMitochondrial dysfunction
05

Safety considerations

Irreversible ototoxicityVestibular toxicityMaternally inherited deafness susceptibility
06

Interacting drugs

Gentamicin

6 more in the full profile.

07

Biomarkers

m.1555A>G mutationm.1494C>T mutation

Beyond the preview

Go deeper on Human mitochondrial 12S ribosomal RNA (MT-RNR1) (MT-RNR1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Human mitochondrial 12S ribosomal RNA (MT-RNR1) (MT-RNR1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call